The United States has established itself as a leading adopter of inhaled nitric oxide therapy due to its advanced healthcare infrastructure, high prevalence of respiratory disorders, and strong emphasis on innovative critical care treatments. The therapy is extensively used in neonatal intensive care units for managing hypoxic respiratory failure and is increasingly being utilized for pulmonary...